TriSalus Life Sciences (TLSIW) Long-Term Investments (2020 - 2023)
TriSalus Life Sciences posted quarterly Long-Term Investments of $12.1 million for Q2 2023, down 95.18% year-on-year from $250.3 million in Q2 2022, and down 40.27% on a QoQ basis from $20.2 million in Q1 2023.
TriSalus Life Sciences (TLSIW) has 4 years of Long-Term Investments data on file, last reported at $12.1 million in Q2 2023.
- For the quarter ending Q2 2023, Long-Term Investments fell 95.18% year-over-year to $12.1 million; the trailing twelve-month figure through Jun 2023 stood at $12.1 million (down 95.18% YoY), and the FY2022 full-year result was $19.8 million, down 92.07% from the prior year.
- Long-Term Investments for Q2 2023 stood at $12.1 million, down from $20.2 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $251.0 million in Q3 2022 and bottomed at $12.1 million in Q2 2023.
- The 4-year median for Long-Term Investments is $250.0 million (2021), against an average of $186.7 million.
- The widest annual swing landed in 2022, when Long-Term Investments grew 0.38%; it then plunged 95.18% in 2023.
- A 4-year view of Long-Term Investments shows it stood at $250.0 million in 2020, then advanced by 0.0% to $250.0 million in 2021, then slumped by 92.07% to $19.8 million in 2022, then sank by 39.09% to $12.1 million in 2023.
- The last three Long-Term Investments figures came in at $12.1 million (Q2 2023), $20.2 million (Q1 2023), and $19.8 million (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 166.25 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | TriSalus Life Sciences | - | - | 7.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 12.08 Mn |
| Mar 31, 2023 | 20.22 Mn |
| Dec 31, 2022 | 19.83 Mn |
| Sep 30, 2022 | 251.02 Mn |
| Jun 30, 2022 | 250.29 Mn |
| Mar 31, 2022 | 250.05 Mn |
| Dec 31, 2021 | 250.01 Mn |
| Sep 30, 2021 | 250.06 Mn |
| Jun 30, 2021 | 250.04 Mn |
| Mar 31, 2021 | 250.04 Mn |
| Dec 31, 2020 | 250.00 Mn |